The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Transarterial chemoembolization combined with atezolizumab plus bevacizumab versus transarterial chemoembolization combined with lenvatinib plus sintilimab as first-line therapy for advanced hepatocellular carcinoma.
 
Ningning Zhang
No Relationships to Disclose
 
Yawei Du
No Relationships to Disclose
 
Yuexi Yu
No Relationships to Disclose
 
Qiang Wu
No Relationships to Disclose
 
Wei Bai
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose
 
Shuwen Zhang
No Relationships to Disclose
 
Wenwen Zhu
No Relationships to Disclose
 
Hao Yu
No Relationships to Disclose
 
Xuanchen Liu
No Relationships to Disclose
 
Ming Luo
No Relationships to Disclose
 
Huiru Liu
No Relationships to Disclose
 
Yiyan Zhang
No Relationships to Disclose
 
Kaipeng Liu
No Relationships to Disclose
 
Yiming Huo
No Relationships to Disclose
 
Guohong Han
No Relationships to Disclose
 
Haipeng Yu
No Relationships to Disclose
 
Jihui Hao
No Relationships to Disclose
 
Wei Lu
No Relationships to Disclose